PRCM _ Cardiology cards Flashcards
Coronary artery disease (CAD)?
- Stable angina - Acute coronary syndrome
Acute coronary syndrome (3)?
- Unstable angina- NSTEMI- STEMI
Angina pectoris - cardiac causes?
Chest pain secondary to myocardial ischemia(1) Stable angina(2) Acute coronary syndromes
Unstable angina v. NSTEMI?
NSTEMI - elevated cardiac enzymes (troponin, CK-MB)Both lack ST segment elevations and pathologic Q waves
T/F: Chest pain relief with nitroglycerin is specific for myocardial ischemia and MI
False - Sublingual nitroglycerin will relieve chest pain secondary to esophageal motor disorder
ST segment changes at less than ___ METS (metabolic equivalents of oxygen consumption) and at less than ___% of age-predicted maximal heart rate indicates a high probability of myocardial ischemia.
6 METS70% of age-predicted maximal heart rate
Angina pectoris: Stable angina v. unstable angina?
Stable angina- Chest pain brought on by exertion or emotion that is relieved with rest or nitroglycerinUnstable angina (1) Chest pain at rest(2) New-onset chest pain that is severe and worsening(3) Chronic chest pain with increasing frequency, duration, or intensity
Major risk factors (7) for coronary artery disease (CAD)?
(1) Diabetes mellitus(2) Hyperlipidemia - high LDL(3) HTN(4) Cigarette smoking(5) Age - men > 45, women > 55(6) Family history of PREMATURE CAD—> MI/sudden cardiac death in MALE first-degree relative < 55 y/o—> MI/sudden cardiac death in FEMALE first-degree relative < 65 y/o (7) Low HDL (< 35) Note: High HDL (> 60) is a negative risk factor (protective)
Worst risk factor for stable angina?
Diabetes mellitus
Most common risk factor for stable angina?
HTN
Goal LDL in patients with CAD?
< 100 mg/dL
Stable angina:Medical therapy (4)?
- Risk factor modification—> Anti-hypertensive—> HMG-CoA reductase inhibitor (statin)—> DM therapy for glucose control- Aspirin- Beta-blocker- Nitrates
Stable angina:First-line beta blockers (2)?
Atenolol, metoprolol
Stable angina:Secondary treatment if symptomatic on beta-blocker and nitrate?
Calcium channel blocker
Stable angina:Risk factor modification -Smoking cessation reduces the risk of CAD by ___% in ___year(s) after quitting.
Smoking cessation reduces the risk of CAD by 50% in 1 year after quitting.
Cardiac catheterization/revascularization methods (2)?
(1) Percutaneous coronary intervention (PCI), also referred to as angioplasty(2) Coronary artery bypass grafting (CABG)
PCI/angioplasty:Complication?
- Re-stenosis is a significant problem, with up to 40% of stents failing within first 6 months- However, if there is no evidence of re-stenosis by 6 months, it usually does not occur
CAD:Poor prognostic indicators (3)?
(1) Two- or three-vessel coronary artery disease(2) Left main coronary artery disease- Supplies approximately 2/3 of the heart(3) Left ventricular dysfunction, with EF < 50%
CABG:Indications (3):
(1) Three-vessel disease, with >70% stenosis in each vessel (especially in diabetics)(2) Left main coronary artery disease, with >50% stenosis (3) Left ventricular dysfunction
Unstable angina:Medical therapy (7)?
- Risk factor modification- Aspirin -and- clopidogrel - Beta-blocker- Nitrates- LMWH (enoxaparin/Lovenox)- Morphine - Oxygen (if patient hypoxic) * consider cardiac catheterization and revascularization *
Management of unstable angina includes repletion of deficient electrolytes, especially ___ (2)?
K+ and Mg2+
Prinzmetal’s angina (coronary artery vasospasm):ECG
- Hallmark is ST segment elevation (not depression) on ECG during chest pain- ST segment elevation resolves when chest pain resolves
Prinzmetal’s angina (coronary artery vasospasm):Definitive test
Coronary angiography displays coronary vasospasm with the administration of IV ergonovine (to provoke chest pain)
Prinzmetal’s angina (coronary artery vasospasm):Medical therapy (2)?
Calcium channel blockersNitrates
Prinzmetal’s angina (coronary artery vasospasm):First-line CCB?
Diltiazem
PCI/angioplasty:Techniques/strategies to reduce high rates of revascularization (2)?
(1) Drug-eluting stents(2) Aspirin + clopidogrel + glycoprotein IIa/IIIb inhibitors
T/F: Revascularization (PCI/CABG) decreases the incidence of MI
False - Revascularization DOES NOT decrease the incidence of MI, but DOES result in significant improvement in symptoms
Myocardial infarction has a ___% mortality rate. ___% of the deaths are pre-hospital.
Myocardial infarction has a 30% mortality rate. 50% of the deaths are pre-hospital.
Chest pain response to nitroglycerin:Stable angina?Unstable angina?NSTEMI/STEMI?
Stable angina: YesUnstable angina: YesNSTEMI/STEMI: No
Cause of sudden cardiac death in the setting of MI?
Ventricular fibrillation (Vfib)
Evolution of ECG findings in MI?
(1) Peaked T waves(2) ST segment elevation(3) Q waves(4) T wave inversion
ST segment:Depression v. elevation?
ST segment depression: Sub-endocardial injury ST segment elevation: Transmural injury
Anterior wall MI:ECG changes?Coronary vessel involved?
Anterior wall MI - ST segment elevation and/or Q waves in leads V1-V4- Occlusion of left anterior descending (LAD) coronary artery
Anteroseptal wall MI:ECG changes?Coronary vessel involved?
Anteroseptal wall MI- ST segment elevation and/or Q waves in leads V1-V2- Occlusion of proximal left anterior descending (LAD) coronary artery
Anterolateral wall MI:ECG changes?Coronary vessel involved?
Anterolateral wall MI- ST segment elevation and/or Q waves in leads V4-V6- Occlusion of left circumflex (LCX) coronary artery
Lateral wall MI:ECG changes?Coronary vessel involved?
Lateral wall MI- ST segment elevation and/or Q waves in leads I, aVL- Reciprocal ST segment depression in leads II, III, aVF- Occlusion of left circumflex (LCX) coronary artery
Posterior wall MI:ECG changes?Coronary vessel involved?
Posterior wall MI - ST segment depression in leads V1 and V2- Prominent R waves in leads V1 and V2- Prominent and upright T waves in leads V1 and V2- ST segment elevation and/or Q waves in POSTERIOR LEADS V7-V9- Occlusion of posterior descending artery (PDA) of right coronary artery (RCA)
Inferior wall MI:ECG changes?Coronary vessel involved?
Inferior wall MI- ST segment elevation and/or Q waves in leads II, III, aVF- Reciprocal ST segment depression in leads I, aVL- Occlusion of right coronary artery (RCA)NOTE- Abdominal discomfort is especially common in inferior wall MIs
ECG that exhibits changes consistent with inferior wall infarction:Next clinical step?
Right-sided ECG with leads V4R, V5R, and V6R
Inferior wall MI with right ventricular infarct/dysfunction:ECG changes?Coronary vessel involved?
Inferior wall MI with right ventricular infarct/dysfunction- ST segment elevation and/or Q waves in leads II, III, aVF- Reciprocal ST segment depression in leads I, aVL- ST segment elevation in leads V3R and V4R on RIGHT-SIDED ECG - Occlusion of right coronary artery (RCA)
Right ventricular infarct:Clinical presentation (4)?
- Hypotension- Clear lungs - Elevated jugular venous pressure- Hepatomegaly
NSTEMI/STEMI:Medical therapy (7)?
“MONA BASH”- Morphine - Oxygen- Nitrates- Aspirin and clopidogrel- Beta-blocker- ACE-inhibitor- Statins- Heparin (enoxaparin/Lovenox)
Medical therapies (3) shown to reduce post-MI mortality?
- Aspirin- Beta-blocker- ACE-inhibitor
Medical therapy shown to reduce post-MI mortality in patients with post-MI LV dysfunction?
Beta-blockers (carvedilol)
Medical therapy shown to reduce post-MI remodeling of the myocardium?
Beta-blockers
Right ventricular infarct:Treatment?
- Generally, RV infarction is treated similarly to STEMIADDITIONS- Volume expansion with IV fluids (usually, normal saline) to increase preload and thereby the blood flow out of the right ventricle SUBTRACTIONS:- NO morphine and NO nitrates, which cause venodilation thereby decreasing preload - NO beta-blockers, which decrease HR and cardiac contractility
Methods of revascularization in STEMI (3)?
(1) Percutaneous coronary intervention (PCI)(2) Thrombolytic therapy(3) Coronary artery bypass graft (CABG)
PCI:Timeframe requirements for indication as preferred method of revascularization?
PCI performed with a door-to-balloon time less than 90 minutes
Thrombolytic therapy: - Timeframe requirements for therapy to be an available method of revascularization?- Timeframe requirements for optimal therapy outcomes?- First-line agent for therapy?
Thrombolytic therapy may be administered up to 24 hours after the onset of angina pectoris (chest pain)Outcomes are best if thrombolytics given within the first 6 hoursFirst-line is alteplase (shown to have best outcomes among thrombolytics)
Post-MI patients should undergo ___ before hospital discharge and should schedule ___ within ___ weeks of discharge.
Post-MI patients should undergo MEASUREMENT OF LV EF% before hospital discharge and should schedule EXERCISE STRESS TEST within 4-6 weeks of discharge.
Post-MI patients have a high risk of ___ during the next 5 years.Risk increases in the setting of what 2 factors?
Post-MI patients have a high risk of STROKE during the next 5 years.The LOWER the EF% and the OLDER the patient, the higher the 5-year risk of stroke
Treatment of premature ventricular contractions (PVCs) post-MI?
None
Treatment of ventricular tachycardia (VT) post-MI in a hemodynamically stable patient?
IV amiodarone
Most common cause of death in first few days post-MI?
Ventricular arrhythmia, either VT or Vfib
Treatment of second-degree (Mobitz II) or third-degree AV block in the setting of anterior wall MI?
Pacemaker
Treatment of second-degree (Mobitz II) or third-degree AV block in the setting of inferior wall MI?
- IV atropine - If conduction is not restored, pacemaker
Post-MI, patients may:- Return to work in?- Resume sexual intercourse in?
- Return to work in 8 weeks - Resume sexual activity in 4-6 weeks
Most common cause of in-hospital death post-MI?
CHF (pump failure) Severe CHF leads to cardiogenic shock
New-onset mitral regurgitation (MR) post-MI?
Papillary muscle rupture
Dressler syndrome:Treatment?
Fever, malaise, fibrinous pericarditis, leukocytosis, and pleuritis weeks to months post-MI (autoimmune etiology)Treatment is aspirin
LDL calculation?
LDL = TC - HDL - (TG/5)TC = Total cholesterolTG = Triglycerides (VLDL)LDL accounts for approximately 2/3 of total cholesterol (TC)
Total cholesterol:- Ideal?- Borderline?- High?
Total cholesterol:- Ideal < 200 - Borderline 200-240- High > 260
LDL:- Ideal?- Borderline?- High?
LDL:- Ideal < 130- Borderline 130-160- High > 160
Triglycerides (VLDL):- Ideal?- Borderline?- High?
Triglycerides (VLDL):- Ideal < 125- Borderline 125-250- High > 250
CAD risk is primarily due to the ___ component of cholesterol because it is thought to be the most atherogenic of all lipoproteins.
LDL
Coronary artery disease (CAD):- Positive risk factor (lipoprotein)?- Mechanism?
- LDL - LDL is proposed to be the most atherogenic of all lipoproteins
Coronary artery disease (CAD):- Negative risk factor (lipoprotein)?- Mechanism?
- HDL- HDL removes excess cholesterol from arterial walls
HDL cholesterol:- HDL level that corresponds to a “negative risk factor” for CAD?- HDL level that corresponds to a “positive risk factor” for CAD?
- Low HDL < 40 is a risk factor for CAD- High HDL > 60 is a negative risk factor (protective) for CAD
HDL cholesterol:- For every 10 mg/dL increase in HDL levels, CAD risk decreases by ___%
For every 10 mg/dL increase in HDL levels, CAD risk decreases by 50%
Total cholesterol-to-HDL ratio:- The lower the TC/HDL ratio, the ___ the risk of CAD
- The lower the total cholesterol-to-HDL ratio, the LOWER the risk of CAD
Total cholesterol-to-HDL ratio and risk of CAD:- Desirable ratio?- Ratio of average (standard) risk?- Ratio of double the risk?- Ratio of triple the risk?
TC/HDL RATIO:- Ratio < 4.5 is desirable- Ratio of 5 is average (standard) risk for CAD- Ratio of 10 is double the risk - Ratio of 20 is triple the risk